TC Biopharm (Holdings) Plc's latest marketcap:
As of 06/26/2025, TC Biopharm (Holdings) Plc's market capitalization has reached $651,946. According to our data, TC Biopharm (Holdings) Plc is the 48304th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 651,946 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -15,215,932 |
| Shares Out | 2.1 M |
| EPS (ttm) | -161.24 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
TC Biopharm (Holdings) Plc's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | $651,946 | -86.1% | 48304 |
| 12/31/2024 | $4.24 M | 207.56% | 48201 |
| 12/29/2023 | $1.38 M | -52.84% | 46527 |
| 12/30/2022 | $2.92 M | 44791 |
Company Profile
About TC Biopharm (Holdings) Plc
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company specializing in innovative immunotherapy solutions. The company leverages its proprietary allogeneic gamma delta T cell platform to develop cutting-edge treatments for cancer and viral infections.
Key Product Pipeline
- OmnImmune – An allogeneic unmodified gamma-delta T cell therapy currently in Phase 2/3 clinical trials for the treatment of acute myeloid leukemia (AML).
- ImmuniStim – An unmodified cell therapy designed to target viral infections and various cancers, offering a broad therapeutic potential.
Company Overview
Founded in 2013, TC Biopharm is headquartered in Motherwell, United Kingdom. The company is dedicated to advancing next-generation immunotherapies to improve patient outcomes globally.
Frequently Asked Questions
-
What is TC Biopharm (Holdings) Plc's (OTC-TCBPY) current market cap?As of 06/26/2025, TC Biopharm (Holdings) Plc (including the parent company, if applicable) has an estimated market capitalization of $651,946 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does TC Biopharm (Holdings) Plc (OTC-TCBPY) rank globally by market cap?TC Biopharm (Holdings) Plc global market capitalization ranking is approximately 48304 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.